GPT and metabolic dysfunction-associated steatotic liver disease: To further investigate the association of the ALT/AST ratio with NAFLD risk, the researchers conducted a stratified analysis and found that the ALT/AST ratio was associated with a reduced risk for NAFLD at age ≥ 70 years, in contrast with other age groups in the assigned subgroup.